Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

Clinical trial NCT00744263 · COMPLETED

Trial details

NCT number: NCT00744263
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pneumonia, Pneumococcal Pneumococcal Infections 13-valent Pneumococcal Vaccine

Start date: 2008-09-01
Primary completion: 2013-10-01
Enrollment: 84496

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.